Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Online telehealth services have democratized access, yet not all platforms operate under equivalent clinical rigor
Call 911 or seek in-person emergency care if you believe you are experiencing a medical emergency
The most important safety consideration is monitoring IGF-1 levels to ensure they remain within therapeutic ranges, as chronically elevated IGF-1 carries theoretical risks (Pollak, 2012)
doi: 10.1016/0021-9673(94)80434-6
Pinning down an exact percentage is difficult because of the many factors involved in measuring nausea in GLP-1 users: GLP-1 in question starting dosage diet dosage compliance use of anti-nausea meds individual definitions of nausea The most comprehensive studies have shown that between 40%65% of GLP-1 patients experience nausea and/or other digestive disturbances, like diarrhea and vomiting
The overall risk appears to be very low, but the theoretical concern necessitates appropriate patient selection and informed consent
